Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Rigo

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
La Radiologia Medica|March 29, 2022
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapyLuca Nicosia, Rosario Mazzola, Claudio Vitale, et al.
La Radiologia Medica|April 13, 2023
Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerabilityLuca Nicosia, Rosario Mazzola, Michele Rigo, et al.
La Radiologia Medica|April 21, 2025
First clinical application of Comprehensive Motion Management with 1.5T MR-linac on prostate cancer patients treated with radiotherapy: technical aspects and suggested workflow recommendationsLuca Nicosia, Michele Rigo, Roberto Giuseppe Pellegrini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 2, 2022
Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factorsFrancesco Cuccia, Rosario Mazzola, Vanessa Figlia, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapyLuca Nicosia, Francesco Cuccia, Rosario Mazzola, et al.
Radiation Oncology (London, England)|September 21, 2021
Patient positioning and immobilization procedures for hybrid MR-Linac systemsFrancesco Cuccia, Filippo Alongi, Claus Belka, et al.
Clinical & Experimental Metastasis|September 6, 2021
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunityFrancesco Cuccia, Rosario Mazzola, Edoardo Pastorello, et al.
The Prostate|November 28, 2025
Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive TechniqueAndrea Romei, Carolina Orsatti, Andrea Gaetano Allegra, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2018
First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastasesFilippo Alongi, Alba Fiorentino, Fabiana Gregucci, et al.
Clinical & Experimental Metastasis|May 5, 2022
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patientsLuca Nicosia, Vanessa Figlia, Nicola Ricottone, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
La Radiologia Medica|March 29, 2022
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapyLuca Nicosia, Rosario Mazzola, Claudio Vitale, et al.
La Radiologia Medica|April 13, 2023
Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerabilityLuca Nicosia, Rosario Mazzola, Michele Rigo, et al.
La Radiologia Medica|April 21, 2025
First clinical application of Comprehensive Motion Management with 1.5T MR-linac on prostate cancer patients treated with radiotherapy: technical aspects and suggested workflow recommendationsLuca Nicosia, Michele Rigo, Roberto Giuseppe Pellegrini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 2, 2022
Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factorsFrancesco Cuccia, Rosario Mazzola, Vanessa Figlia, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 14, 2020
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapyLuca Nicosia, Francesco Cuccia, Rosario Mazzola, et al.
Radiation Oncology (London, England)|September 21, 2021
Patient positioning and immobilization procedures for hybrid MR-Linac systemsFrancesco Cuccia, Filippo Alongi, Claus Belka, et al.
Clinical & Experimental Metastasis|September 6, 2021
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunityFrancesco Cuccia, Rosario Mazzola, Edoardo Pastorello, et al.
The Prostate|November 28, 2025
Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive TechniqueAndrea Romei, Carolina Orsatti, Andrea Gaetano Allegra, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2018
First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastasesFilippo Alongi, Alba Fiorentino, Fabiana Gregucci, et al.
Clinical & Experimental Metastasis|May 5, 2022
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patientsLuca Nicosia, Vanessa Figlia, Nicola Ricottone, et al.
Pageof 5